21 Oct 2021 | 02:45 PM GMT

Digital Health in Mental Health: Commercialization Models

About this Meeting

What are the best commercialisation models for digital companies in the mental health space?  

 The current poor accessibility to services, lack of objective tests and stigma, make mental health one of the most promising areas for digital health companies, especially now that the pandemic has boosted the demand for mental health services. Digital health products offer diagnosis, management and treatment not only for mental health conditions by themselves but also a secondary treatment to mental health conditions that coexist with chronic diseases like cancer, psoriasis, etc. We have seen promising clinical evidence on multiple occasions (a couple of examples: GAD; insomnia & depression), but beyond evidence and outcomes, getting paid for these solutions is one of the biggest challenges. Join us in this informal conversation to discuss: 

  •  What are the most scalable and sustainable routes to market for digital health companies in the mental health space (e.g employers, other risk-bearing entities, D2C, partnerships with pharma, medtech, etc)? What are the keys to success? 
  •  Factors that determine the best commercialization model (e.g geographies, disease, objective of the program -prevention, diagnosis, management, treatment, etc-, others).  
  •  Implications of choosing one route to market vs. others (evidence requirements, pricing strategies, HCPs & health coaches involvement, organization structure of the company, etc)